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A forthcoming article in Nature reveals that inflammasome deficiency disturbs gut microbiota and predis-
poses to diet-induced obesity and liver disease. The aberrant microbiota and its consequences could be
transferred by cohousing mutant and wild-type mice, suggesting that some aspects of metabolic syndrome
can be communicable (Henao-Mejia et al., 2012).The dramatic increase in metabolic
diseases, including obesity, type 2 dia-
betes, and nonalcoholic fatty liver disease
(NAFLD) over the last half-century, amidst
relatively constant human genetics, indi-
cates that environmental and/or lifestyle
factors are driving this alarming trend.
While much attention has, rightly, been
focused on diet, some recent studies
describe an important role for aberrations
in gut microbiota composition in pro-
moting such disorders. This notion is
supported by observations that rodents
placed on high-fat diets (HFD) that, at
the macronutrient level, resemble com-
mon diets in western countries develop
numerous features of metabolic syn-
drome while mice placed on methionine/
choline-deficient diets (MCDD) develop
NAFLD. While the mechanisms by which
such diets and alterations in gut micro-
biota promote these diseases differ, they
all involve enhancement of proinflamma-
tory signaling, which can lead to dysfunc-
tion in metabolic signaling, for example by
desensitizing receptors including those
that detect insulin and leptin (Gregor and
Hotamisligil, 2011).
Some proinflammatory cytokines, es-
pecially select members of the IL-1 super
family, have a wide variety of hormone-
like properties that directly impact metab-
olism in a complex manner. For example,
mice lacking IL-1b are protected from
diet-induced metabolic disease, whereas
mice deficient in IL-18 develop sponta-
neous metabolic syndrome (Netea et al.,
2006). Commensurate with their broad
roles in host defense, marked effects on
metabolism, and ability to drive inflamma-
tory disease, expression of IL-1b and
IL-18 is not primarily simply regulated at
the transcriptional level. Rather, these
cytokines are synthesized as inactive
precursors, which are then processed bya tightly regulated process to produce
mature bioactive IL-1b and IL-18. Such
processing is mediated by the inflam-
masome complex whose components
include caspase-1 and adaptor proteins,
which comprise the processing ma-
chinery, and various members of the
nod-like receptor (NLR) family of proteins
that activate the complex upon detection
of microbial products and host-derived
danger signals.
In a recent study, Henao-Mejia and
colleagues confirm the importance of
IL-18 in protecting against metabolic
disease and determine the effect is
mediated through the gut microbiota
(Henao-Mejia et al., 2012). They observed
that mice lacking NLRP3 and NLRP6, two
NLRs that activate the inflammasome in
response to detection of foreign protein
and/or host-derived danger signals, are
highly prone to both MCDD-induced
NAFLD and HFD-induced metabolic syn-
drome. The conclusion that this pheno-
type resulted from loss of inflamma-
some-mediated IL-18 production came
from their observation that the liver-
disease prone phenotype of the NLRP3
and NLRP6 mice was similar to that ex-
hibited by mice lacking inflammasome
machinery, or the gene for IL-18, but not
IL-1b. Importantly, the authors discovered
a novel role of the gut microbiota in
explaining why loss of inflammasome-
mediated IL-18 production predisposed
mice to diet-induced metabolic disease.
Specifically, they observed that NLRP6-
and NLRP3-deficient mice developed
alterations in their gut microbiota that
resulted in the translocation of bacterial
products from the gut into the systemic
circulation (including the liver), which
activated toll-like receptors (TLR) 4 and
9 (Figure 1). Activation of both TLR4 and
TLR9 was necessary for predispositionCell Metabolismto diet-induced since genetic deletion of
either TLR prevented severe manifesta-
tions of diet-induced disease. The finding
that gut microbiota composition, which is
inherited from one’s early environments
and shaped by host genetics, influences
liver disease and other manifestations
of metabolic syndrome reinforces the
notion that microbiota is a major deter-
minant of phenotypes associated with
inflammation.
While many studies have associated
changes in gut microbiota composi-
tion with disease, Henao-Mejia et al.
demonstrated that the microbiota of
NLRP6- and NLRP3-deficient mice,
which featured elevated Prevotellaceae
and Porphyromonadaceae species, was
functionally important in disease patho-
genesis. They showed that microbiota
transfer from mutant mice predisposed
WT mice to diet-induced NAFLD, indi-
cating that alteredmicrobiotawas a cause
rather than consequence of this pheno-
type. The findings that innate immune
deficiency can result in a microbiota that
promotes metabolic disease are analo-
gous to that described for mice lacking
TLR2 and TLR5 (Caricilli et al., 2011;
Vijay-Kumar et al., 2010). However, in
those cases, the disease-promoting
microbiota was transferred via transplant
of cecal contents to WT germ-free mice,
which are known to be extremely sus-
ceptible to being colonized by any
bacteria they encounter. In contrast,
Henao-Mejia et al. found that simple
cohousing of NLRP3- and NLRP6-
deficient mice was sufficient for micro-
biota transfer to conventional WT mice,
even though the WT mice already
had a well-established microbiota. This
major distinction has a very important
public health implication. Specifically,
transfer of disease-prone phenotype to15, April 4, 2012 ª2012 Elsevier Inc. 419
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Figure 1. Proposed Mechanism by which Loss of
NLRP3 and NLRP6 Promotes Diet-Induced Metabolic
Disease
The flow chart outlines how loss NLRP3 or NLRP6 inflamma-
some promotes inflammatory signaling that can promote
diet-induced disease.
Cell Metabolism
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notion that microbiota can actually
affect phenotype and suggests
a potential role for early environment
in which microbiota are acquired. In
contrast, transfer of disease
promoting microbiota from mutant
mice to conventional WT mice by
simply cohousing them suggests
the possibility that predisposition to
develop metabolic syndrome can
actually be an acquired chronic
infectious disease.
However, it should be noted that,
because mice are coprophagic,
spread of intestinal bacteria is likely
to be considerably more efficient in
mice than humans. Thus, it will be
important to determine the extent
to which cohabitation of adult hu-mans results in transfer of their gut micro-
biotas. It will also be important to better
understand how loss of NLRP3 or
NLRP6 alters microbiota composition,
which will likely require identifying the
ligands, likely bacterial, that these NLRs
normally recognize.420 Cell Metabolism 15, April 4, 2012 ª2012Thus, this study by Richard Flavell and
collaborators supports the notion, previ-
ously suggested by epidemiological
studies, that the interrelated epidemics
of obesity, type 2 diabetes, NAFLD, and
other facets of metabolic syndrome might
be, in part, driven by infectious agents.Elsevier Inc.Given that microbiota composition
can be altered by a variety of factors
including diet, antibiotics, and infec-
tious agents, these results raise the
possibility that individuals might
be effected by the actions of their
close associates in ways we are
only beginning to appreciate.
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